September 8, 2011 – A randomized multicenter, open-label study evaluating the efficacy and safety of prolonged ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer ...
September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for managing ...
August 30, 2011 – Compared with patients who had persistently high platelet reactivity, those who achieved low platelet ...
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
Aug. 2, 2011 — New York University (NYU) Langone Medical Center received an $84 million grant from the National Heart ...
July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...
July 5, 2011 — Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
June 14, 2011 – New performance measures for adults with coronary artery disease (CAD) and hypertension were released ...
June 10, 2011 – The U.S. Food and Drug Administration (FDA) announced safety label changes for the cholesterol-lowering ...
June 3, 2011 – European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet ...
April 22, 2011 – A new study found that coronary artery bypass surgery added to medical therapy for selected ...
April 21, 2011 – A new angiotensin II receptor blocker (ARB) has been approved by the U.S. Food and Drug ...
April 21, 2011 – Baxter International has entered into a definitive agreement to acquire privately-held Prism ...